会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • Preparation and use of photopolymerized microparticles
    • 光聚合微粒的制备和应用
    • US20050192371A1
    • 2005-09-01
    • US11070506
    • 2005-03-02
    • Theodore RandolphKristi AnsethJennifer OwensCorinne Lengsfeld
    • Theodore RandolphKristi AnsethJennifer OwensCorinne Lengsfeld
    • A61K9/16C08F2/06C08F2/18C08F2/46C08K3/00
    • A61K9/1635A61K9/1694C08F2/06C08F2/18C08F2/46Y10T428/2982Y10T428/2984Y10T428/2985Y10T428/2989
    • Methods of forming crosslinked polymer particles in situ from polymer precursors such as monomers or oligomers, comprising exposing a composition comprising at least one polymer precursor, a solvent or solvent mixture, and an antisolvent or antisolvent mixture to photoradiation under conditions whereby particles are formed are provided. The polymer precursor may be photosensitive, or a separate polymerization initiator may be used. In a preferred embodiment, the polymer precursor is insoluble in the antisolvent or antisolvent mixture and the solvent or solvent mixture is soluble in the antisolvent or antisolvent mixture at the concentrations used. Crosslinked polymer particles and crosslinked polymer particles comprising a polymer and a bioactive material are also provided. The polymer may be erodable, and the polymer particles formed may be used in a variety of applications, including controlled release of bioactive materials such as drugs. Polymer particles formed using the methods of the invention have low residual solvent levels and high additive encapsulation efficiencies. The processes of the invention allow control of particle size and morphology, use low operating temperatures and are useful for efficient bulk production.
    • 提供从聚合物前体如单体或低聚物原位形成交联聚合物颗粒的方法,包括将包含至少一种聚合物前体,溶剂或溶剂混合物的组合物以及抗溶剂或抗溶剂混合物暴露于形成颗粒的条件下进行光引发 。 聚合物前体可以是光敏的,或者可以使用单独的聚合引发剂。 在优选的实施方案中,聚合物前体不溶于抗溶剂或抗溶剂混合物,溶剂或溶剂混合物可以以所使用的浓度溶于抗溶剂或抗溶剂混合物。 还提供了交联聚合物颗粒和包含聚合物和生物活性材料的交联聚合物颗粒。 聚合物可能是可侵蚀的,并且形成的聚合物颗粒可以用于各种应用中,包括诸如药物的生物活性材料的控制释放。 使用本发明方法形成的聚合物颗粒具有低的残留溶剂水平和高的添加剂包封效率。 本发明的方法允许控制颗粒尺寸和形态,使用低的操作温度,并且可用于高效批量生产。
    • 8. 发明授权
    • Preparation and use of photopolymerized microparticles
    • 光聚合微粒的制备和应用
    • US06403672B1
    • 2002-06-11
    • US09451481
    • 1999-11-30
    • Theodore RandolphKristi AnsethJennifer L. OwensCorinne Lengsfeld
    • Theodore RandolphKristi AnsethJennifer L. OwensCorinne Lengsfeld
    • C08F246
    • A61K9/1694A61K9/1635C08F2/06C08F2/18C08F2/46
    • Methods of forming polymer particles in situ from polymer precursors such as monomers or oligomers, comprising exposing a composition comprising at least one polymer precursor, a solvent or solvent mixture, and an antisolvent or antisolvent mixture to photoradiation under conditions whereby particles are formed are provided. The polymer precursor may be photosensitive, or a separate polymerization initiator may be used. In a preferred embodiment, the polymer precursor is insoluble in the antisolvent or antisolvent mixture and the solvent or solvent mixture is soluble in the antisolvent or antisolvent mixture at the concentrations used. Polymer particles comprising a polymer and a bioactive material are also provided. The polymer may be erodable, and the polymer particles formed may be used in a variety of applications, including controlled release of bioactive materials such as drugs. Polymer particles formed using the methods of the invention have low residual solvent levels and high additive encapsulation efficiencies. The processes of the invention allow control of particle size and morphology, use low operating temperatures and are useful for efficient bulk production.
    • 提供从聚合物前体例如单体或低聚物原位形成聚合物颗粒的方法,其包括将包含至少一种聚合物前体,溶剂或溶剂混合物的组合物以及抗溶剂或抗溶剂混合物暴露于形成颗粒的条件下进行光引发。 聚合物前体可以是光敏的,或者可以使用单独的聚合引发剂。 在优选的实施方案中,聚合物前体不溶于抗溶剂或抗溶剂混合物,溶剂或溶剂混合物可以以所使用的浓度溶于抗溶剂或抗溶剂混合物。 还提供了包含聚合物和生物活性材料的聚合物颗粒。 聚合物可能是可侵蚀的,并且形成的聚合物颗粒可以用于各种应用中,包括诸如药物的生物活性材料的控制释放。 使用本发明方法形成的聚合物颗粒具有低的残留溶剂水平和高的添加剂包封效率。 本发明的方法允许控制颗粒尺寸和形态,使用低的操作温度,并且可用于高效批量生产。
    • 10. 发明授权
    • Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
    • 用于药物递送和组织工程的半互穿或互穿聚合物网络
    • US07625580B1
    • 2009-12-01
    • US09724382
    • 2000-11-28
    • Robert S. LangerJennifer ElisseeffKristi AnsethDerek Sims
    • Robert S. LangerJennifer ElisseeffKristi AnsethDerek Sims
    • A61K2/02
    • A61L27/50A61L27/38A61L27/3817A61L27/3852A61L27/52A61L2400/06A61L2430/06
    • Compositions for tissue engineering and drug delivery have been developed based on solutions of two or more polymers which form semi-interpenetrating or interpenetrating polymer networks upon exposure to active species following injection at a site in a patient in need thereof. The polymers crosslink to themselves but not to each other; semi-interpenetrating networks are formed when only one of the polymers crosslink. The resulting viscous solutions retain the biologically active molecules or cells at the site of injection until release or tissue formation, respectfully, occurs.As a result of studies conducted with polymer-cell suspensions forming interpenetrating polymer networks, it has been determined that polymer solutions can be formulated wherein the active species is provided by exposure of the polymer solution to an exogenous source of active species, typically electromagnetic radiation, preferably light. Studies demonstrate that light will penetrate through skin, body fluids (such as synovial fluid) and membranes and polymerize the polymer solutions. The polymer solutions can be crosslinked ionically or covalently, to form a hydrogel, semi-interpenetrating polymer network or an interpenetrating polymer network.
    • 已经开发了用于组织工程和药物递送的组合物,其基于在需要其的患者的部位注射后暴露于活性物质时形成半互穿或互穿聚合物网络的两种或更多种聚合物的溶液。 聚合物自身交联而不是彼此交联; 当只有一种聚合物交联时,形成半互穿网络。 所得粘稠溶液将生物活性分子或细胞保留在注射部位,直到发生释放或组织形成。 作为通过形成互穿聚合物网络的聚合物 - 细胞悬浮液进行的研究的结果,已经确定可以配制聚合物溶液,其中通过将聚合物溶液暴露于外源性活性物质(通常是电磁辐射)来提供活性物质, 最好是光。 研究表明,光将穿透皮肤,体液(如滑液)和膜,并聚合聚合物溶液。 聚合物溶液可以离子交换或共价交联,以形成水凝胶,半互穿聚合物网络或互穿聚合物网络。